Cite
MLA Citation
Bradley Monk et al.. “O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial.” International journal of gynecological cancer, vol. 32, n.d., pp. A2–A3. http://access.bl.uk/ark:/81055/vdc_100170500694.0x00003c